LCP: Assay, Glycosylated Hemoglobin

Product code LCP, “Assay, Glycosylated Hemoglobin” in FDA's classification database, is a Class II device type under 21 CFR 864.7470 (glycosylated hemoglobin assay), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 249 clearances under LCP, 49 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
LCP
Regulation
21 CFR 864.7470
Class
II
Panel
Hematology
Clearances
249
Most recent
Nov 22, 2024
Median review, last 2 years
931 days
Third-party review
Not eligible
Implant
No

What it covers

A glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient.

The identification in 21 CFR 864.7470, glycosylated hemoglobin assay. FDA gives LCP no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerNova Biomedical CorporationNov 22, 2024Dual Track
K231465Q-Pad Test SystemQurasenseDec 6, 2023Traditional
K214117Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 AnalyzerAbbott Diagnostics Technologies ASSep 27, 2023Dual Track
K192987Aina HbA1c Monitoring System 2Jana Care, Inc.Mar 26, 2020Traditional
K192369PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitIxensor Co, Ltd.Oct 29, 2019Traditional
K183230OneDraw A1C Test SystemDrawbridge Health, Inc.Aug 15, 2019Traditional
K181915PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitIxensor Co, Ltd.Apr 12, 2019Traditional
K180509Quo-Test A1c SystemEkf-Diagnostic GmbHFeb 16, 2019Dual Track
K173127skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent Kit)Skyla Corporation H.S.P.BSep 25, 2018Traditional
K170623ACE Hemoglobin A1c (HbA1c) ReagentAlfa Wassermann Diagnostic Technologies, LLCFeb 27, 2018Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 249 with a free account)

Clearances by year

49 LCP 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20241931
20232419
20201153
20194269
20182362
20175218
20162372
20153239
20148127
2013229
20129143
201110176

Who submits

37 applicants cleared a LCP device since 2011. 73% of the clearances went to applicants in United States, then Taiwan (8%), Norway (6%) and Japan (4%). By type: Traditional 73%, Special 20% and Dual Track 6%.

ApplicantClearances since 2011
Beckman Coulter, Inc.3
Bio-Rad Laboratories, Inc., Clinical Systems Divis3
Diazyme Laboratories3
Sebia3
Infopia Co, Ltd.2
Ixensor Co, Ltd.2
Sakae Corporation2
Siemens Healthcare Diagnostics2

How FDA classifies it

Class II (performance standards).

From 21 CFR 864.7470.

Standards

21 CFR 864.7470 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LCP clearances declared.

Ask about LCP

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about LCP

What is FDA product code LCP?

Product code LCP, “Assay, Glycosylated Hemoglobin” in FDA's classification database, is a Class II device type under 21 CFR 864.7470 (glycosylated hemoglobin assay), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 249 clearances under LCP, 49 of them since 2011.

How many 510(k) clearances are there under LCP?

FDA’s 510(k) database listed 249 clearances under LCP as of Oct 29, 2026, 49 of them decided since 2011; the most recent decision was Nov 22, 2024. The Predicate Finder searches the live database.

How long does FDA take to clear a LCP 510(k)?

For the 1 LCP clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 931 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most LCP clearances?

Since 2011: Beckman Coulter, Inc. (3), Bio-Rad Laboratories, Inc., Clinical Systems Divis (3), Diazyme Laboratories (3), Sebia (3) and Infopia Co, Ltd. (2). 37 applicants have cleared a LCP device in that time.

Sources

  1. FDA product classification: LCP · Product Classification database
  2. 21 CFR 864.7470: Glycosylated hemoglobin assay · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for LCP · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow LCPGet an email when FDA clears, recalls or publishes guidance for LCP devices.

Know what FDA already cleared.